CLINICAL_TRIALS
ClinicalTrials.gov record update
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer Expressing NY-ESO-1 or LAGE-1.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00199836
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:57.411301+00:00
- Published At
- 2021-07-15T00:00:00+00:00
- Record Updated At
- 2022-10-10
- Results Posted At
- 2021-07-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Cancer", "Neoplasm"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-10-10"- protocolSection.identificationModule.nctId
"NCT00199836"- protocolSection.identificationModule.officialTitle
"A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide\u00ae ISA-51 in Patients With Cancer Expressing NY-ESO-1 or LAGE-1."- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-07-15"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.